Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Direct healthcare costs for 5 years post-fracture in Canada: a long-term population-based assessment.

Leslie WD, Lix LM, Finlayson GS, Metge CJ, Morin SN, Majumdar SR.

Osteoporos Int. 2013 May;24(5):1697-705. doi: 10.1007/s00198-012-2232-2. Erratum in: Osteoporos Int. 2013 Nov;24(11):2901.

PMID:
23340947
2.

Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization.

Budhia S, Mikyas Y, Tang M, Badamgarav E.

Pharmacoeconomics. 2012 Feb 1;30(2):147-70. doi: 10.2165/11596880-000000000-00000. Review.

PMID:
22187933
3.
4.

Epidemiology of osteoporotic fractures.

Johnell O, Kanis J.

Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7. Review.

PMID:
15365697
5.

Osteoporosis in the European Union: a compendium of country-specific reports.

Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA; EU Review Panel of IOF..

Arch Osteoporos. 2013;8:137. doi: 10.1007/s11657-013-0137-0. Review.

6.

The incidence of fragility fractures in Italy.

Ratti C, Vulcano E, La Barbera G, Canton G, Murena L, Cherubino P.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S13-4. doi: 10.1007/s40520-013-0071-4. Review.

PMID:
24046040
7.

Epidemiology and economic burden of osteoporosis in Switzerland.

Svedbom A, Ivergård M, Hernlund E, Rizzoli R, Kanis JA.

Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Review.

PMID:
24970672
8.

Epidemiology of hip fractures.

Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M.

Bone. 1996 Jan;18(1 Suppl):57S-63S. Review.

PMID:
8717549
9.

The socioeconomic burden of fractures: today and in the 21st century.

Johnell O.

Am J Med. 1997 Aug 18;103(2A):20S-25S; discussion 25S-26S. Review.

PMID:
9302894
10.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
11.

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.

Si L, Winzenberg TM, de Graaff B, Palmer AJ.

Osteoporos Int. 2014 Aug;25(8):1987-97. doi: 10.1007/s00198-014-2636-2. Review.

PMID:
24562840
12.

A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures.

Si L, Winzenberg TM, Palmer AJ.

Osteoporos Int. 2014 Jan;25(1):51-60. doi: 10.1007/s00198-013-2551-y. Review.

PMID:
24154803
13.

Public health impact of osteoporosis.

Cauley JA.

J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1243-51. doi: 10.1093/gerona/glt093. Review.

14.

Costs and consequences of hip fracture occurrence in old age: an economic perspective.

Haentjens P, Lamraski G, Boonen S.

Disabil Rehabil. 2005 Sep 30-Oct 15;27(18-19):1129-41. Review.

PMID:
16278182
15.
16.

Healthcare Costs to Poor Families: An Agonising Burden.

Kissoon N.

Indian J Pediatr. 2016 Oct;83(10):1063-4. doi: 10.1007/s12098-016-2170-7. Review. No abstract available.

PMID:
27272049
Items per page

Supplemental Content

Support Center